Antimicrobial resistance (AMR) is one of the greatest challenges in infectious disease today. The pipeline of new antibiotics is thin, resistance mechanisms continue to evolve, and clinicians often have to make treatment decisions before traditional susceptibility data returns. AI-powered analysis of sequencing data is starting to change that equation.
What BIOTIA-DX Resistance does
BIOTIA-DX Resistance applies AI to microbial genomic and metagenomic data to detect and interpret antimicrobial resistance genes — including variants and novel mechanisms that rule-based systems miss. The output is a structured, actionable resistance profile that clinical teams and researchers can interpret quickly.
Why AI matters here
Resistance gene catalogs are large, growing, and incomplete. Traditional approaches — exact matches against curated databases — miss any resistance gene that hasn't been described before, or any meaningful variant of one that has. Machine-learning models trained on the structure and function of resistance genes can generalize, flagging likely resistance mechanisms even when an exact reference is not available — a capability that matters for both global post-pandemic AMR surveillance and tracking resistance genes carried by international travelers.
From data to decisions
Sequencing data is only useful if it can be acted on. BIOTIA-DX Resistance is built around the workflows that clinical microbiology labs and resistance-surveillance programs actually use — surfacing the signal that matters for the next clinical decision, not just dumping a wall of gene IDs into a report.
What's next
Biotia continues to publish on AMR detection, surveillance, and the practical use of AI in clinical genomics. Watch for upcoming webinars and peer-reviewed work from the team.
Frequently asked questions
What is BIOTIA-DX Resistance?
BIOTIA-DX Resistance is an AI-powered analytical tool for detecting and interpreting antimicrobial resistance genes from microbial sequencing data. It supports both clinical decision-making and research workflows.
Why use AI for resistance detection?
Traditional rule-based resistance prediction misses novel and variant resistance genes. Machine-learning models can generalize from known examples to flag previously unseen resistance mechanisms in genomic and metagenomic data.
Who is this for?
Clinical microbiology labs, hospital infection control teams, biopharma resistance-surveillance programs, and academic researchers studying the evolution and spread of AMR.